Fetal ischemia monitoring with in vivo implanted electrochemical multiparametric microsensors

dc.contributor.author
Dulay, Samuel
dc.contributor.author
Rivas, Lourdes
dc.contributor.author
Pla, Laura
dc.contributor.author
Berdún Marin, Sergio
dc.contributor.author
Eixarch Roca, Elisenda
dc.contributor.author
Gratacós Solsona, Eduard
dc.contributor.author
Illa Armengol, Míriam
dc.contributor.author
Mir Llorente, Mònica
dc.contributor.author
Samitier i Martí, Josep
dc.date.issued
2022-01-04T14:21:08Z
dc.date.issued
2022-01-04T14:21:08Z
dc.date.issued
2021-12-20
dc.date.issued
2022-01-03T10:36:48Z
dc.identifier
1754-1611
dc.identifier
https://hdl.handle.net/2445/182131
dc.identifier
6542782
dc.identifier
34930385
dc.description.abstract
Under intrauterine growth restriction (IUGR), abnormal attainment of the nutrients and oxygen by the fetus restricts the normal evolution of the prenatal causing in many cases high morbidity being one of the top-ten causes of neonatal death. The current gold standards in hospitals to detect this relevant problem is the clinical observation by echography, cardiotocography and Doppler. These qualitative techniques are not conclusive and requires risky invasive fetal scalp blood testing and/or amniocentesis. We developed micro-implantable multiparametric electrochemical sensors for measuring ischemia in real time in fetal tissue and vascular. This implantable technology is designed to continuous monitoring for an early detection of ischemia to avoid potential fetal injury. Two miniaturized electrochemical sensors were developed based on oxygen and pH detection. The sensors were optimized in vitro under controlled concentration, to assess the selectivity and sensitivity required. The sensors were then validated in vivo in the ewe fetus model, by means of their insertion in the muscle leg and inside the iliac artery of the fetus. Ischemia was achieved by gradually obstructing the umbilical cord to regulate the amount of blood reaching the fetus. An important challenge in fetal monitoring is the detection of low levels of oxygen and pH changes under ischemic conditions, requiring high sensitivity sensors. Significant differences were observed in both; pH and pO2 sensors under changes from normoxia to hypoxia states in the fetus tissue and vascular with both sensors. Herein, we demonstrate the feasibility of the developed sensors for future fetal monitoring in medical applications.
dc.format
11 p.
dc.format
application/pdf
dc.language
eng
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13036-021-00280-7
dc.relation
Journal Of Biological Engineering, 2021, num. 15
dc.relation
https://doi.org/10.1186/s13036-021-00280-7
dc.relation
info:eu-repo/grantAgreement/EC/H2020/712754/EU//BEST
dc.rights
cc by (c) Dulay, Samuel et al, 2021
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Enginyeria Electrònica i Biomèdica)
dc.subject
Monitoratge fetal
dc.subject
Isquèmia
dc.subject
Fetal monitoring
dc.subject
Ischemia
dc.title
Fetal ischemia monitoring with in vivo implanted electrochemical multiparametric microsensors
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.